Company / Return on Equity (ROE)
Envista Holdings Return on Equity (ROE) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
1.5%
FY2025
5-year range
-38.1% / 8.4%
FY2021-FY2025
Trend
+104.0%
vs FY2024
Sector context
#82 of 147
Health Care
What the data says
At 1.5%, Envista Holdings's return on equity (roe) ranks #82 of 147 in the Health Care sector. Return on Equity (ROE) returned to growth in FY2025 after 3 years of decline, reaching 1.5%.
Based on SEC 10-K filings.
1.5% in FY2025 with a 5-year CAGR of +0.6%.
Improved from -2.4% to 1.5% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -4.3pp
- 5-Year Change
- +0.6pp
- 10-Year Change
- -
Sector benchmark
#82 of 147 in Health CareTop 56% of 147This company 1.5% Sector average -3.1%
▼
+148.4% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 104.0% year-over-year.
- Currently 4.6pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.5% | +104.0% |
| FY2024 | -38.1% | -1488.3% |
| FY2023 | -2.4% | -141.5% |
| FY2022 | 5.8% | -31.1% |
| FY2021 | 8.4% | +832.2% |
| FY2020 | 0.9% | -85.4% |
| FY2019 | 6.2% | +28.7% |
| FY2018 | 4.8% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026